Trials / Conditions / Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
4 registered clinical trials studyying Nodal Peripheral T-Cell Lymphoma With TFH Phenotype — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Other NCT06561048 | Corvus Pharmaceuticals, Inc. | Phase 3 |
| Recruiting | A Registry for People With T-cell Lymphoma NCT05978141 | Memorial Sloan Kettering Cancer Center | — |
| Suspended | Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma NCT04803201 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Active Not Recruiting | Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas NCT03598998 | City of Hope Medical Center | Phase 1 / Phase 2 |